1,8-Naphthyridine derivatives as Cholinesterases Inhibitors and Cell Ca2+ Regulators, a Multitarget Strategy for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|22|2807-2823

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.22, 2011-11, pp. : 2807-2823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer’s Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 33, 2015-11 ,pp. : 3789-18

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 6, 2015-07 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies of N-hydroxy 1,8-naphthyridine 2-one Analogs as Ribonuclease H Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 9, 2013-11 ,pp. : 823-835

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer’s Disease Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 537-548

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Cholinesterases Inhibitors for Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 14, Iss. 25, 2007-10 ,pp. : 2654-2679

Bentham Science Publishers

Access to resources Recommend Favorite